Tan Li
Förmögenhet: 599 M $ per 2026-05-31
Förmögenhet: 599 M $ per 2026-05-31
Tan Li is the founder of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., established in 1998, holding the title of Executive Director & Deputy General Manager since its founding.
Current jobs include Non-Executive Director at Kymab Ltd., Director at Shenzhen Techdow Pharmaceutical Co., Ltd., Director at Shenzhen Duopule Industrial Development Co., Ltd. since 2014, Director at Kymab Group Ltd. since 2017, and Executive Partner at Urumqi Jintiantu Equity Investment Partnership LP since 2013.
Education history includes an undergraduate degree from Sichuan University, conferred in 1987.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-09-30 | 408 041 280 ( 32,72 % ) | 599 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Grundare | 1998-04-21 |
Urumqi Jintiantu Equity Investment Partnership LP | Företagsledare/Principal | 2013-08-09 |
Shenzhen Techdow Pharmaceutical Co., Ltd. | Direktör/Styrelseledamot | - |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Direktör/Styrelseledamot | 2014-01-13 |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Direktör/Styrelseledamot | - |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Direktör/Styrelseledamot | 2017-01-20 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in production of heparin products | Health Technology |
Urumqi Jintiantu Equity Investment Partnership LP | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Distribution Services |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån